Modafinil Treatment for Sleep/Wake Disturbances in Older Adults
Sponsor: VA Palo Alto Health Care System
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from VA Palo Alto Health Care System
Other Alzheimer Disease trials with similar outcome
Listed as NCT00626210, this PHASE4 trial focuses on Alzheimer Disease and Insomnia and remains terminated or withdrawn. Sponsored by VA Palo Alto Health Care System, it has been updated 10 times since 2008, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE4
-
Dec 2021 — Dec 2022 [monthly]
Terminated PHASE4
▶ Show 5 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE4
-
Nov 2019 — Jan 2021 [monthly]
Terminated PHASE4
-
Jun 2018 — Nov 2019 [monthly]
Terminated PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE4
First recorded
Feb 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- VA Palo Alto Health Care System
For direct contact, visit the study record on ClinicalTrials.gov .